There is no publicly available rating for this medical professional for one of the following reasons:
Adults (18-65), Geriatrics (65+)
Adults (18-65), Geriatrics (65+)
Perelman Center for Advanced Medicine
3400 Civic Center Boulevard
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
Mohiuddin Jahan J, Chu Brian, Facciabene Andrea, Poirier Kendra, Wang Xingmei, Doucette Abigail, Zheng Cathy, Xu Wei, Anstadt Emily J, Amaravadi Ravi K, Karakousis Giorgos C, Mitchell Tara C, Huang Alexander C, Shabason Jacob E, Lin Alexander, Swisher-McClure Samuel, Maity Amit, Schuchter Lynn M, Lukens John N: Association of antibiotic exposure with survival and toxicity in patients with melanoma receiving immunotherapy. Journal of the National Cancer Institute : 2020.
Jain Varsha, Hwang Wei-Ting, Venigalla Sriram, Nead Kevin T, Lukens John N, Mitchell Tara C, Shabason Jacob E: Association of Age with Efficacy of Immunotherapy in Metastatic Melanoma. The oncologist 25 (2): e381-e385,2020.
Jain Varsha, Venigalla Sriram, Reddy Vishruth K, Lukens John N, Mitchell Tara C, Shabason Jacob E: Association of Insurance Status With Presentation, Treatment, and Survival in Melanoma in the Era of Immune Checkpoint Inhibitors. Journal of immunotherapy (Hagerstown, Md. : 1997) 43 (1): 8-15,2020.
Jain Varsha, Venigalla Sriram, Sebro Ronnie A, Karakousis Giorgos C, Wilson Robert J, Weber Kristy L, Shabason Jacob E: Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma. Cancer medicine 8 (14): 6295-6304,2019.
Lee Daniel Y, Staddon Arthur P, Shabason Jacob E, Sebro Ronnie: Phase I and phase II clinical trials in sarcoma: Implications for drug discovery and development. Cancer medicine 8 (2): 585-592,2019.
Shwetha Manjunath and Jacob E. Shabason: The Safety and Efficacy of Combined Immunotherapy and Radiation Therapy Applied Radiation Oncology : 2019.
Venigalla Sriram, Guttmann David M, Horne Zachary D, Carmona Ruben, Shabason Jacob E, Beriwal Sushil: Definitive local therapy is associated with improved overall survival in metastatic cervical cancer. Practical radiation oncology 8 (6): e377-e385,2018.
Venigalla Sriram, Carmona Ruben, Guttmann David M, Jain Varsha, Freedman Gary M, Clark Amy S, Shabason Jacob E: Use and Effectiveness of Adjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer in Men. JAMA oncology 4 (10): e181114,2018.
Wojcieszynski Andrzej P, Hullett Craig R, Medlin Erin E, Taunk Neil K, Shabason Jacob E, Brower Jeffrey V, Chen Shuai, Bekelman Justin E, Barroilhet Lisa M, Bradley Kristin A: The role of radiation therapy in the treatment of Stage II endometrial cancer: A large database study. Brachytherapy 17 (4): 645-652,2018.
Shabason Jacob E, Chen Jerry, Apisarnthanarax Smith, Damjanov Nevena, Giantonio Bruce, Loaiza-Bonilla Arturo, O'Dwyer Peter J, O'Hara Mark, Reiss Kim A, Teitelbaum Ursina, Wissel Paul, Drebin Jeffrey A, Vollmer Charles, Kochman Michael, Mick Rosemarie, Vergara Norge, Jhala Nirag, Doucette Abigail, Lukens John N, Plastaras John P, Metz James M, Ben-Josef Edgar: A phase I dose escalation trial of nab-paclitaxel and fixed dose radiation in patients with unresectable or borderline resectable pancreatic cancer. Cancer chemotherapy and pharmacology 81 (13): 609-614,2018.
3400 Civic Center BlvdTRC 2 West
Patient appointments: 800-789-7366
Proton therapy is a non–invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy cancer cells.
Our experienced cancer nurses and referral staff are here to help. Call 800-789-7366 (PENN) or complete an online request.
Learn more about the benefits of translational research at Penn Medicine.